Genesco (GCO) Q1 2027 earnings summary

Executive summary

• Net sales rose to $487 million in Q1 FY27, up 3% year-over-year, with comparable sales up 2% and e-commerce accounting for 24% of retail sales.

• Achieved seventh consecutive quarter of positive comparable sales, led by Journeys (+5%) and Johnston & Murphy (+7%), while Schuh faced declines due to a weaker UK market.

• Gross margin improved by 30 basis points to 47.0%, driven by reduced promotions and operational efficiencies.

• Operating margin improved to (3.2)% from (5.9)% year-over-year, with adjusted operating loss narrowing to $23.9 million.

• Announced a $40–$50 million cost savings program and raised full-year adjusted EPS outlook to $2.00–$2.40.

Financial highlights

• Q1 revenue increased 3% year-over-year to $487 million, with gross margin at 47.0% (up 30 bps) and adjusted SG&A at 51.9% of sales (60 bps leverage).

• GAAP operating loss was $15.4 million, non-GAAP operating loss $23.9 million; GAAP EPS was ($1.42), non-GAAP EPS ($2.18).

• Inventory increased 6% year-over-year to $477 million, mainly to support Journeys 4.0 expansion.

• Trailing 12-month sales per square foot increased 9%.

• Total liquidity stood at ~$353 million at quarter-end.

Outlook and guidance

• Raised full-year adjusted EPS guidance to $2.00–$2.40, reflecting Q1 outperformance and a more cautious UK outlook.

• Full-year comparable sales growth expected at 1–2%, with total sales flat to down 1%.

• Gross margin projected to improve 50–60 basis points; adjusted operating income guidance increased to $34–$40 million.

• CapEx planned at $65–$70 million, with 90–95% allocated to stores.

• Q2 expected to be the most pressured quarter, with comps flat to slightly down and EPS $0.20–$0.30 lower year-over-year due to tax rate effects.